Compare with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SHASUN PHARMA ALKEM LABORATORIES/
SHASUN PHARMA
 
P/E (TTM) x 21.9 123.9 17.7% View Chart
P/BV x 5.3 8.5 61.8% View Chart
Dividend Yield % 0.9 0.2 394.4%  

Financials

 ALKEM LABORATORIES   SHASUN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
SHASUN PHARMA
Mar-14
ALKEM LABORATORIES/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,72094 2,887.5%   
Low Rs1,66046 3,641.1%   
Sales per share (Unadj.) Rs697.9214.2 325.8%  
Earnings per share (Unadj.) Rs96.15.3 1,801.4%  
Cash flow per share (Unadj.) Rs117.315.8 741.2%  
Dividends per share (Unadj.) Rs25.001.00 2,500.0%  
Dividend yield (eoy) %1.11.4 79.8%  
Book value per share (Unadj.) Rs515.253.3 965.9%  
Shares outstanding (eoy) m119.5756.62 211.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.3 961.6%   
Avg P/E ratio x22.813.1 173.9%  
P/CF ratio (eoy) x18.74.4 422.7%  
Price / Book Value ratio x4.31.3 324.4%  
Dividend payout %26.018.7 138.8%   
Avg Mkt Cap Rs m261,8793,958 6,616.9%   
No. of employees `00014.3NA-   
Total wages/salary Rs m15,0552,164 695.9%   
Avg. sales/employee Rs Th5,822.6NM-  
Avg. wages/employee Rs Th1,050.5NM-  
Avg. net profit/employee Rs Th802.0NM-  
INCOME DATA
Net Sales Rs m83,44412,127 688.1%  
Other income Rs m1,042229 454.4%   
Total revenues Rs m84,48612,356 683.8%   
Gross profit Rs m14,7341,009 1,460.2%  
Depreciation Rs m2,528594 425.8%   
Interest Rs m651415 156.7%   
Profit before tax Rs m12,598230 5,484.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105-73 -1,519.3%   
Profit after tax Rs m11,493302 3,804.2%  
Gross profit margin %17.78.3 212.2%  
Effective tax rate %8.8-31.7 -27.7%   
Net profit margin %13.82.5 552.9%  
BALANCE SHEET DATA
Current assets Rs m54,9606,884 798.3%   
Current liabilities Rs m32,4338,456 383.6%   
Net working cap to sales %27.0-13.0 -208.3%  
Current ratio x1.70.8 208.1%  
Inventory Days Days8062 129.1%  
Debtors Days Days72108 67.1%  
Net fixed assets Rs m32,7104,970 658.1%   
Share capital Rs m239113 211.0%   
"Free" reserves Rs m61,3682,875 2,134.6%   
Net worth Rs m61,6073,020 2,039.8%   
Long term debt Rs m1,5921,817 87.6%   
Total assets Rs m99,43313,347 745.0%  
Interest coverage x20.41.6 1,310.9%   
Debt to equity ratio x00.6 4.3%  
Sales to assets ratio x0.80.9 92.4%   
Return on assets %12.25.4 227.3%  
Return on equity %18.710.0 186.5%  
Return on capital %21.013.3 157.3%  
Exports to sales %19.146.4 41.1%   
Imports to sales %3.014.2 20.9%   
Exports (fob) Rs m15,9175,622 283.1%   
Imports (cif) Rs m2,4831,728 143.7%   
Fx inflow Rs m16,0615,843 274.9%   
Fx outflow Rs m2,4832,173 114.3%   
Net fx Rs m13,5783,669 370.0%   
CASH FLOW
From Operations Rs m5,851398 1,471.5%  
From Investments Rs m-7,414-1,635 453.4%  
From Financial Activity Rs m7921,309 60.5%  
Net Cashflow Rs m-73171 -1,026.8%  

Share Holding

Indian Promoters % 66.9 39.2 170.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 3.6 919.4%  
FIIs % 0.0 17.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 39.6 -  
Shareholders   68,381 20,750 329.5%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   VENUS REMEDIES  ORCHID PHARMA  SANOFI INDIA  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Feb 26, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS